Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 6851814

Corpus cavernosography.

S Frouws·J W Reeders·A A Valcke
View original source ↗Export metadata ↓

Abstract

The cavernous spaces of the penis can be demonstrated by injecting 20 cm3 contrast agent (Urografin 60%) dorsolaterally behind the gland penis. By injecting the contrast agent into one corpus cavernosum, both corpora become visible by X-ray. Pathologic conditions (trauma, Peyronie's disease, priapism, malignancy, etc.) cause typical changes in the cavernous spaces and blood drainage. The literature has been reviewed.

Explore related subjects

Diatrizoate MeglumineHumansMalePenile IndurationPenile NeoplasmsPenisPriapismProstheses and ImplantsRadiographyRuptureJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Frouws, J W Reeders, A A Valcke. 1983. Corpus cavernosography.. https://pubmed.ncbi.nlm.nih.gov/6851814/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Peroperative Gastrograffin bowel lavage in gastroschisis.

AIMS: The aim of the study was to evaluate potential benefits in the use of peroperative bowel lavage with Gastrograffin in neonates with gastroschisis. METHODS: A retrospective analysis of newborns with gastroschisis was performed over a 10-year period in 2 centers in the United Kingdom. Two groups were studied wherein one had peroperative bowel lavage with Gastrograffin and the other did not. RESULTS: Data were collected on 116 patients of whom 93 were suitable for analysis. There were no statistically significant differences in primary closure rate, duration of ventilation, parenteral nutrition, or hospital stay. Intestinal obstruction occurred more frequently in the nonlavage group. CONCLUSION: Gastrograffin lavage peroperatively in gastroschisis offers no potential advantage in reducing ventilatory requirements, parenteral nutrition, and hospital stay. It also does not achieve greater primary closure rates, but may reduce the incidence of intestinal obstruction.

Diatrizoate Meglumine↗